Gasparri Maria Luisa, Kuehn Thorsten, Ruscito Ilary, Zuber Veronica, Di Micco Rosa, Galiano Ilaria, Navarro Quinones Siobana C, Santurro Letizia, Di Vittorio Francesca, Meani Francesco, Bassi Valerio, Ditsch Nina, Mueller Michael D, Bellati Filippo, Caserta Donatella, Papadia Andrea, Gentilini Oreste D
Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, via Tesserete 46, 6900 Lugano, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), via Giuseppe Buffi 13, 6900 Lugano, Switzerland.
Cancers (Basel). 2021 Apr 24;13(9):2056. doi: 10.3390/cancers13092056.
use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy.
randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes.
twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin's disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied ( < 0.0001, < 0.005, = 0.008).
fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found.
盆腔、腹主动脉旁及腹股沟淋巴结清扫术后使用纤维蛋白封闭剂可能降低淋巴系统相关并发症的发生率。本荟萃分析的目的是评估这一发现是否适用于腋窝淋巴结清扫术。
纳入评估纤维蛋白封闭剂在减少腋窝淋巴并发症方面疗效的随机试验。将淋巴囊肿、引流量、手术部位并发症及住院时间作为观察指标。
纳入23项随机研究,其中患者接受腋窝淋巴结清扫术治疗乳腺癌、黑色素瘤及霍奇金病。纤维蛋白封闭剂对腋窝淋巴囊肿发生率及手术部位并发症无影响。应用纤维蛋白封闭剂后,引流量、引流天数及住院时间均减少(<0.0001,<0.005,=0.008)。
腋窝淋巴结清扫术后使用纤维蛋白封闭剂可减少腋窝总引流量、引流持续时间及住院时间。未发现对术后淋巴囊肿发生率及手术部位并发症发生率有影响。